BioSpace News Archive

Drug Development

NeuroRx Announces Completion of Data Analysis in Phase 2b/3 Clinical Trial of ZYESAMI™ for the Treatment of COVID-19 Respiratory Failure

NeuroRx, Inc. announces completion of top line data analysis of the 60-day results in its phase 2b /3 clinical trial, conducted under FDA Fast Track Designation, of ZYESAMI™

March 26, 2021
·
6 min read
Deals

Nordic Nanovector ASA - allocation of PSUs - Mar 26, 2021

The Board of Directors of Nordic Nanovector ASA has on 26 March 2021 decided to grant 1,070,000 Performance Share Units to employees in accordance with the authorisation granted at the Annual General Meeting held on 10 June 2020.

March 26, 2021
·
4 min read
Business

Biotage AB (publ) publishes its 2020 Annual Report, Corporate Governance Report and Remuneration Report

Biotage’s 2020 Annual Report, Corporate Governance Report and Remuneration Report are as of today available at: www.biotage.com This is information that Biotage AB (publ) is obliged to make public pursuant to the Securities Markets Act.

March 26, 2021
·
1 min read
BioCapital

FDA Authorizes Marketing of Device to Improve Gait in Multiple Sclerosis Patients

Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis (MS).

March 26, 2021
·
6 min read
Deals

NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ) - Mar 26, 2021

The shareholders in Biotage AB, Reg. No. 556539-3138, with its registered office in Uppsala kommun, Uppsala län, are hereby summoned to the Annual General Meeting, to be held on Wednesday, 28 April 2021.

March 26, 2021
·
28 min read
FDA

Medtronic Receives FDA Approval for Breakthrough Transcatheter Pulmonary Valve Replacement for Patients with Congenital Heart Disease

Harmony™ Transcatheter Pulmonary Valve is First Minimally Invasive Alternative for Patients with Severe Pulmonary Regurgitation Who Have a Native or Surgically-Repaired Right Ventricular Outflow Tract

March 26, 2021
·
4 min read
Business

Genscript Biotech Reports Full Year 2020 Financial Results

Highlights: Revenue of the Group for the year ended December 31, 2020 was approximately US$390.8 million , representing an increase of 42.9% as compared with approximately US$273.4 million for the year ended December 31, 2019

March 26, 2021
·
7 min read
Policy

European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin

Enfortumab vedotin to be reviewed under accelerated assessment for the treatment of locally advanced or metastatic urothelial cancer

March 26, 2021
·
13 min read
Deals

Gyroscope Therapeutics Announces $148 Million Raised in Series C Financing

Gyroscope Therapeutics Limited, a clinical-stage gene therapy company focused on treating diseases of the eye, announced it has raised USD $148.0 million in a Series C financing.

March 26, 2021
·
5 min read
Genetown

Quanterix’ Simoa Technology Demonstrates Advancements in COVID-19 Research through Viral Antigen Measurements in Blood and Saliva Samples

Company’s SARS-CoV-2 N-Protein Assay measures viral antigen in plasma, dried blood spots and saliva in more than 90 percent of COVID-19 PCR+ positive donors, including those without symptoms

March 26, 2021
·
6 min read